Overview

Study to Test the Safety and Efficacy of Padsevonil as Adjunctive Treatment of Focal-onset Seizures in Adult Subjects With Drug-resistant Epilepsy

Status:
Completed
Trial end date:
2020-12-11
Target enrollment:
Participant gender:
Summary
The purpose of the study is to evaluate the long-term safety and tolerability of Padsevonil administered at individualized doses as adjunctive treatment for subjects with drug-resistant epilepsy.
Phase:
Phase 2/Phase 3
Details
Lead Sponsor:
UCB Biopharma S.P.R.L.